These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin. Brorson JE; Norrby R Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150 [No Abstract] [Full Text] [Related]
6. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice. Goering RV; Sanders CC; Sanders W J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989 [TBL] [Abstract][Full Text] [Related]
7. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin. Fraser DG Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032 [No Abstract] [Full Text] [Related]
8. [Clinico-microbiologic bases for the use of new cephalosporins]. De Bac C; Mascellino MT; Nuti M Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006 [No Abstract] [Full Text] [Related]
9. Intravenous treatment of systemic infections in 20 patients with cefoxitin sodium. Laplante L; Bastien E; Giroux Y; Girard R J Antimicrob Chemother; 1978 Jul; 4(B):219-22. PubMed ID: 357391 [No Abstract] [Full Text] [Related]
11. [Cefamandel--in-vitro activity and pharmacokinetics]. Simon C; Nixdorf F Med Welt; 1979 Apr; 30(14):527-30. PubMed ID: 431391 [No Abstract] [Full Text] [Related]
12. The cephalosporins: activity and clinical use. Weinstein AJ Drugs; 1980 Aug; 20(2):137-54. PubMed ID: 6995096 [TBL] [Abstract][Full Text] [Related]
13. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines. Barry AL; Jones RN; Thornsberry C Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092 [TBL] [Abstract][Full Text] [Related]
14. Use of cefoxitin sodium in difficult-to-treat infections. Ramachandran Nair S; Cherubin CE J Antimicrob Chemother; 1978 Jul; 4(B):167-78. PubMed ID: 357383 [No Abstract] [Full Text] [Related]
15. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins. Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403 [TBL] [Abstract][Full Text] [Related]
16. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin]. Mirimanoff RO; Héraïef E Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276 [No Abstract] [Full Text] [Related]
17. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins]. Torres A; Aguirre M; Ales JM Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674 [No Abstract] [Full Text] [Related]
18. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Tartaglione TA; Polk RE Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits. Mader JT; Wilson KJ J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327 [No Abstract] [Full Text] [Related]